Adverse renal outcomes following targeted therapies in renal cell carcinoma: a systematic review and meta-analysis
Introduction: To clarify the prevalence of adverse renal outcomes following targeted therapies in renal cell carcinoma (RCC).Methods: A systematic search was performed in MEDLINE, EMBASE, and Cochrane Central Library. Studies that had reported adverse renal outcomes following targeted therapies in R...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2024-06-01
|
| Reeks: | Frontiers in Pharmacology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1409022/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|